A silent heart attack often goes unnoticed, posing serious health risks. Understand symptoms, risk factors, and prevention strategies for better heart health.
Structure Therapeutics has the potential to have a best-in-class GLP-1 agonist drug for treatment of patients with obesity. Learn more on GPCR stock here.